<DOC>
	<DOC>NCT01538875</DOC>
	<brief_summary>Hypertensive crisis (defined as a systolic pressure &gt; 160mmHg or a diastolic pressure &gt; 110mmHg) in patients with a hypertensive disorder of pregnancy is a serious complication with severe and even deadly consequences. The management in this population had been studied, but no consensus has been reached with regards to which treatment is better. Our study will compare two drugs: Hydralazine and Labetalol for the management of hypertensive crisis.</brief_summary>
	<brief_title>Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of Pregnancy</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension, Pregnancy-Induced</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Labetalol</mesh_term>
	<mesh_term>Hydralazine</mesh_term>
	<criteria>Gestational age &gt; 24 weeks. Hypertensive Crisis (systolic pressure &gt; 160 mmHg / diastolic pressure &lt; 110mmHg). Known allergy to hydralazine. Known allergy to labetalol. Severe Bradycardia</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Hypertension, pregnancy induced</keyword>
	<keyword>Hydralazine</keyword>
	<keyword>Labetalol</keyword>
</DOC>